We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Panel to Schedule Meeting on Cellegesic
FDA Advisory Panel to Schedule Meeting on Cellegesic
February 24, 2006
An FDA advisory panel this spring will discuss Cellegy Pharmaceuticals’ new drug application (NDA) for the pain-relief gel Cellegesic, which has a proposed indication of relieving pain associated with anal fissures.